The purpose of this study was to investigate the expression of NRP‐1/CD304 in BPDCN and other common hematological diseases, and to systematically evaluate its diagnostic efficacy, thus to guide the panel design of flow immunophenotyping in diagnosis and MRD of various hematological diseases. This evidence concerns the gene NRP1 and CD4+/CD56+ hematodermic neoplasm.